HIV / AIDS in the News

Protecting access to HIV care in a time of disruption - Unitaid

 

[AIDS 2026] aidsmap: Monthly PrEP pill could be made for US$3 a year, but Latin America is shut out of generic licensing - European AIDS Treatment Group

 

[AIDS 2026] Countries in Latin America and the Caribbean helped build the future of HIV prevention. But will they be able to benefit from it? - European AIDS Treatment Group

 

Once-weekly oral tablet proves highly effective for HIV care - News-Medical

 

Historic Funding Drop Threatens Global HIV Progress - Infectious Disease Special Edition

 

Idvynso Maintains Suppression Despite Archived Resistance Mutations - Infectious Disease Special Edition

 

Meet the Ohio nun who has been working on the frontlines of HIV/AIDS work for decades - The Buckeye Flame

 

Can the Immune System Control HIV Without ART? - TheBody

 

Long-acting Cabenuva beats daily oral HIV therapy in adolescents | AIDS 2026 - Managed Healthcare Executive

 

Over 7,000 Students Aged 18-25 Test HIV Positive In Karnataka: Why The State Govt Is Conducting Mandatory H - News18

 

Hepatitis B Virus Vaccines Underperform in People Living With HIV - The American Journal of Managed Care

 

Raphael Landovitz, M.D., on HIV prevention gains, gaps | AIDS 2026 - Managed Healthcare Executive

 

Water insecurity nearly quadruples odds of poor HIV outcomes, while hunger and partner violence compound risk in East Africa - Aidsmap

 

‘It’s Like Jenga’: Ohio advocates warn federal funding cuts will undermine HIV prevention - Cleveland.com

 

Cabenuva demonstrates superiority to daily oral therapy in adolescents living with HIV, as ViiV Healthcare highlights new long-acting injectable data at AIDS 2026 - GSK

 

Donor Government Funding for HIV Dropped by $2.1 Billion in 2025 Due to Declines in U.S. Disbursements, Marking the Largest Annual Decrease Since HIV Response Scale Up Began - KFF

 

Two Drugs Matched Three for Untreated HIV - MedPage Today

 

AIDS 2026 Research Shows Individualized HIV Treatment Is Shaping the Future - Infection Control Today

 

AIDS 2026: New HIV Data Support More Personalized Treatment Options - Infection Control Today

 

AIDS 2026: New targets for metabolic dysfunction despite ART - BioWorld News

 

Trump ends direct HIV prevention funding to community groups - Rough Draft Atlanta

 

Why is Latin America still waiting for long-acting HIV prevention? - Devex

 

Lancet Report Recommends Paradigm Shift in Care for Older Adults with HIV - POZ

 

Long-acting HIV treatment still out of reach in low- and middle-income countries, says UCSF's Monica Gandhi | AIDS 2026 - Managed Healthcare Executive

 

Report reveals consequences of Trump's HIV/AIDS funding cuts - THIRTEEN - New York Public Media

 

New HIV Frontier: The Fight To Access Long-Acting Prevention Drugs - Health Policy Watch

 

The Next Step on the Path to an HIV Cure - amfAR, The Foundation for AIDS Research

 

America’s 250th: Reflecting on Progress Against HIV - POZ

 

How US HIV funding cuts quickly affected care in East Africa - medicalxpress.com

 

Lloyd Mulenga, M.B.Ch.B., Ph.D., on Zambia’s ‘basic minimum package’ | AIDS 2026 - Managed Healthcare Executive